Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,643 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,643 in last 12 months

Showing 46814700 of 13,380 recalls

DrugJanuary 28, 2020· Teva Pharmaceuticals USA

Recalled Item: Tramadol Hydrochloride Tablets USP CIV Recalled by Teva Pharmaceuticals USA...

The Issue: Labeling: Incorrect package insert - Patient leaflets for the specified lots...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 27, 2020· Teva Pharmaceuticals USA

Recalled Item: Desmopressin Acetate Tablets Recalled by Teva Pharmaceuticals USA Due to GMP...

The Issue: GMP Deviations: Product bottle may be absent of desiccant.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 27, 2020· Teva Pharmaceuticals USA

Recalled Item: Methylphenidate hydrochloride Extended-Release ablets USP (CII) Recalled by...

The Issue: CGMP deviations: Product bottle may be absent of desiccant.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 27, 2020· Teva Pharmaceuticals USA

Recalled Item: Desmopressin Acetate Tablets Recalled by Teva Pharmaceuticals USA Due to GMP...

The Issue: GMP Deviations: Product bottle may be absent of desiccant.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 27, 2020· Teva Pharmaceuticals USA

Recalled Item: Methylphenidate hydrochloride Extended-Release ablets USP (CII) Recalled by...

The Issue: CGMP deviations: Product bottle may be absent of desiccant.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2020· Breckenridge Pharmaceutical, Inc

Recalled Item: Solifenacin Succinate Tablets Recalled by Breckenridge Pharmaceutical, Inc...

The Issue: CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2020· Macleods Pharma Usa Inc

Recalled Item: Pioglitazone and Metformin Hydrochloride Tablets Recalled by Macleods Pharma...

The Issue: Subpotent Drug: Out of specification assay result, below specification, for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 24, 2020· Ascend Laboratories LLC

Recalled Item: Olmesartan Medoxomil Tablets 20 mg Recalled by Ascend Laboratories LLC Due...

The Issue: cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2020· Breckenridge Pharmaceutical, Inc

Recalled Item: Solifenacin Succinate Tablets Recalled by Breckenridge Pharmaceutical, Inc...

The Issue: CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 22, 2020· Ascend Laboratories LLC

Recalled Item: Minocycline Hydrochloride Extended-Release Tablets Recalled by Ascend...

The Issue: Failed Dissolution Specifications: low out of specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 20, 2020· Macleods Pharma Usa Inc

Recalled Item: Montelukast Sodium Chewable Tablets Recalled by Macleods Pharma Usa Inc Due...

The Issue: Failed Dissolution Specifications: testing revealed low out of specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 16, 2020· Shandex Personal Care Manufacturing Inc.

Recalled Item: Walgreens Acne Cleansing Bar Recalled by Shandex Personal Care Manufacturing...

The Issue: Presence of Foreign Substance; Metal contaminant visible in product (screen...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Glutathione Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Alprostadil (prostaglandin E1) 80 MCG/ML Injectable Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Glycine Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Methionine/Inositol/Choline Injection Recalled by Fusion IV Pharmaceuticals,...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Triamcinolone Diacetate Injectable Suspension Recalled by Fusion IV...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: MIC-PLUS Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Lidocaine HCL (PF) Injection Recalled by Fusion IV Pharmaceuticals, Inc. dba...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund